| INTRODUCTION
Nemaline myopathy (NM) is a rare genetic disorder that primarily affects skeletal muscle resulting in generalized weakness, which is typically proximal in location, hypotonia, and depressed deep tendon reflexes. This congenital myopathy is characterized by an accumulation of nemaline bodies, which are rod-like inclusions located inside the myofibers that can be detected by Gomori trichome staining (Wallgren-Pettersson, Sewry, Nowak, & Laing, 2011) . The phenotypic spectrum ranges from mild, adult-onset to severe congenital forms (Wallgren-Pettersson et al., 2011) . The congenital type comprises approximately 16% of all NM cases (Ryan et al., 2001 ) and classically presents with decreased fetal movements, severe hypotonia, muscle weakness, feeding difficulties, and respiratory insufficiency in the neonatal period (Ryan et al., 2001) . In contrast to earlier-onset forms, adult-onset forms typically occur sporadically and may be associated with monoclonal gammopathy of unknown significance (Schnitzler et al., 2017) .
NM is genetically heterogeneous, and pathogenic variants in 12
genes have been associated with this disorder (Gurung et al., 2017;  Megan Abbott and Mahim Jain contributed equally.
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wileyonlinelibrary.com/journal/ajmga Malfatti et al., 2015; Massalska et al., 2016; Miyatake et al., 2017; Seferian et al., 2016) . Pathogenic variants in six of these genes (NEB, ACTA1, TPM3, KLHL40, KLHL41, and LMOD3) have been associated with the severe congenital phenotype (Gupta et al., 2013; Nowak et al., 1999; Pelin et al., 1999; Ravenscroft et al., 2013; Tan et al., 1999; Yuen et al., 2014 encodes for a protein known as leiomodin-3, which is located in the actin thin filaments of skeletal and cardiac muscle. Deficiency of leimodin-3 results in disorganization of thin filaments, decreased muscle function, and nemaline bodies with unique morphology (Yuen et al., 2014) .
Here, we describe a consanguineous family whose three daughters presented with decreased fetal movements, hypotonia, muscle weakness, respiratory distress, and long bone fractures noted at birth.
The three siblings died within days after birth due to respiratory insufficiency. Given the finding of fractures at birth, osteogenesis imperfecta was considered in the differential diagnosis. However, using whole exome sequencing (WES), the subjects were later confirmed to have a homozygous pathogenic variant in LMOD3 and were diagnosed postmortem with severe congenital myopathy, which is presumed to be NM, although tissue was not available to confirm the presence of nemaline bodies. There is only one previous report describing a cohort of 21 individuals from 14 families with a pathogenic variant in LMOD3
causing congenital myopathy or confirmed NM but only two of the subjects in this report had fractures (Yuen et al., 2014 (Yang et al., 2013) . Sequence reads were aligned (hg19), processing, variant calling, and annotation were completed using the MERCURY pipeline (Reid et al., 2014) . Variants were filtered for allele frequency of less than 1% in the ExAC database v0.3 (Lek et al., 2016) and 1,000 genomes project phase 3 (Genomes Project C et al., 2015) .
| Sanger sequencing
To confirm the variant detected by WES, primers were designed to amplify exon 1 of LMOD3 (F: GTTAACTGGGGGACCTTCTTG, R: CCAAACCCTGGAGTCTTGAG) in samples from the probands and parents. Polymerase chain reaction was performed using 2 ng/uL of DNA and GoTaq polymerase (Promega, Madison, WI) as per manufacturer's instructions to amplify exon 1 with the primers listed above. PCR products were confirmed using agarose gel electrophoresis. The samples were submitted for Sanger Sequencing (Beckman Coulter Genomics, Danvers, MA) using the same primers.
| RESULTS
WES was performed using DNA from proband II.2 and revealed an apparently homozygous, previously reported, pathogenic variant in LMOD3 (NM_001304418: c.138dupC, p.Ser47GlnfsTer13) (Yuen et al., 2014) . This variant was confirmed by Sanger sequencing, and
Sanger sequencing confirmed that the proband's affected sibling (II.3) was also apparently homozygous for this same variant. No DNA was available from the other affected sibling (II.1). Sanger sequencing of DNA samples from the parents revealed that both parents are heterozygous for this variant (Figure 1 ). No pathogenic variants in known genes associated with low bone mass or osteogenesis imperfecta were identified, and no other pathogenic variants in known myopathy genes were identified.
| DISCUSSION
The probands, who presented with decreased fetal movements, muscle weakness, perinatal fractures, and respiratory compromise leading to death in early infancy, were found to have a homozygous frameshift pathogenic variant in LMOD3 that was previously reported in three other subjects with severe congenital NM and that has been previously associated with no protein expression (Yuen et al., 2014) . All three probands were critically ill after delivery with diffuse edema, respiratory insufficiency, and abnormal neurologic examination including hypotonia and muscle weakness which is consistent with the phenotype of severe congenital myopathy. None of the three subjects had arthrogryposis which was observed in a subset of subjects in the previously published cohort of individuals with LMOD3 variants (Yuen et al., 2014) . Tissue was not available for histopathologic analysis or electron microscopy to determine if nemaline rods were present. Interestingly, the nemaline rods in LMOD3-associated congenital myopathy are unique as compared to those identified in other forms of NM as they appear similar to remnants of the thickened Z-disc with surrounding thin filaments that are shortened (Yuen et al., 2014) . In the absence of tissue histology, as in these cases, molecular testing may facilitate a diagnosis.
LMOD3 encodes for a protein known as leiomodin-3 which is expressed in both cardiac and skeletal muscle with highest expression levels in skeletal muscle (Yuen et al., 2014) . It is expressed at early stages of skeletal muscle differentiation, which may be why loss of function typically results in a severe congenital phenotype (Yuen et al., 2014) .
Loss of this protein results in short and non-functional sarcomeres (Yuen et al., 2014) . In a mouse model, loss of leiomodin-3 caused replacement of the sarcomeres by nemaline bodies and glycogen granules, which create an irregular and disorganized myofiber structure (Cenik et al., 2015) . Others have shown atrophy of fast twitch muscle fibers in LMOD3 deficient mice (Tian et al., 2015) .
Congenital fractures are classically linked to either trauma or osteogenesis imperfecta (Morgan & Marcus, 2010) . However, other rare disorders, such as Ehlers-Danlos type VIIC (caused by a pathogenic variant in ADAMTS2) can be associated with perinatal fractures (Solomons et al., 2013) (Table 1) Congenital fractures are not uncommon in severe, congenital myopathies. In one study 7/23 cases of severe congenital NM surveyed had congenital fractures (Ryan et al., 2001) . Another study demonstrated that 10/19 individuals with severe congenital NM caused by pathogenic variants in KLHL40 had pathologic fractures . The fractures reported in severe congenital NM and neuromuscular diseases predominantly involve long bones (femur/humerus), and in such cases, the bones have been reported to be hypomineralized and thin (Ryan et al., 2001) , with callus and/or remodeling present, suggesting intrauterine origin (Buonocore, Balestri, Toti, & Bagnoli, 1993; . The predominant explanation for fractures in severe congenital NM is limited fetal movement , and all three of our probands likely suffered from fetal akinesia secondary to their myopathy. Another theory is that the fractures are sustained on delivery (Hall, 2014) . It has historically been recommended that all infants with known arthrogryposis be delivered by cesarean section to reduce the risk of fractures associated with delivery (Hall, 2014) .
However, a recent study evaluated antenatal outcome in patients with osteogenesis imperfecta who were delivered via cesarean section versus vaginal delivery and found no difference in fracture rate (Bellur et al., 2016) .
This study suggested that fracture prevention should not be the sole motivation in choosing cesarean section (Bellur et al., 2016) . No conclusive evidence exists as to whether cesarean section results in decreased fracture prevalence in NM when compared to vaginal delivery.
In conclusion, congenital myopathy can present in the neonatal period with congenital fractures. Specifically, this is the second report describing pathogenic variants in LMOD3 causing a severe congenital myopathy phenotype associated with perinatal fractures (Yuen et al., 2014) . It is unclear if some fractures occur or are worsened by delivery, necessitating the need to handle any infant with a known diagnosis of congenital myopathy, such as NM, with care during delivery and the perinatal period. LMOD3-associated congenital myopathy or NM, should be considered in the differential diagnosis for neonatal (or prenatal) fractures especially in the setting of severe hypotonia, to facilitate early diagnosis and the provision of appropriate genetic counseling.
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